Member Exclusive News

The week in industry: New antibody optimisation agreement between IONTAS and Teva Pharmaceuticals

This week: Novel drug for binge eating disorder given approval by FDA, new wave of funding for Europe’s largest brain and tissue bank and Aridis Pharmaceuticals (CA, USA) and Serum International BV (Amsterdam, Netherlands) enter into exclusive license agreement

Go to the profile of RxNet
Aug 01, 2019
0
0

Please sign in or register for FREE

No comments yet.